rhinosinusitis%20-%20acute,%20bacterial%20(pediatric)
RHINOSINUSITIS - ACUTE, BACTERIAL (PEDIATRIC)
Rhinosinusitis is the mucosal inflammation of the nose and paranasal sinuses caused by bacteria lasting >10 days for up to 4 weeks, symptoms resolve completely and may either be persistent or severe.
It is often preceded by a viral upper respiratory tract infection.
Signs & symptoms are nonspecific and it is typically difficult to differentiate from viral upper respiratory tract infection.
Streptococcus pneumoniae is the most common cause followed by nontypeable Haemophilus influenzae.

Rhinosinusitis%20-%20acute,%20bacterial%20(pediatric) Signs and Symptoms

Definition

  • Acute rhinosinusitis is defined as sudden onset of ≥2 of the following symptoms for <12 weeks:
    • Nasal blockage/obstruction/congestion
    • Discolored nasal discharge
    • Daytime or night-time cough
    • Facial pressure or pain
  • Acute bacterial rhinosinusitis is defined as mucosal inflammation of the nose and paranasal sinuses caused by bacteria lasting >10 days for up to 4 weeks symptoms resolve completely and may either be persistent or severe
  • Often preceded by a viral upper respiratory tract infection (URTI)
    • It is a common complication of viral URTI or allergic inflammation

Etiology

  • Streptococcus pneumoniae is the most common cause followed by nontypeable Haemophilus influenzae
  • 3rd most common pathogen is Moraxella catarrhalis
  • Streptococcus pyogenes, respiratory anaerobes, Staphylococcus aureus are less common bacterial causes

Signs and Symptoms

  • Signs and symptoms are nonspecific and it is typically difficult to differentiate from viral upper respiratory infection (URTI)
  • Major symptoms include anterior and/or posterior mucopurulent drainage, nasal obstruction, facial pressure/pain/fullness, hyposmia/anosmia, and fever
  • Less common signs and symptoms include fatigue, headache, ear pressure/discomfort, halitosis, cough, and maxillary dental pain

Risk Factors

  • Most common predisposing factors are viral upper respiratory tract infection (URTI) and allergic inflammation
  • Other predisposing factors
    • Anatomic (eg nasal foreign bodies, septal deviation, tumor, trauma)
    • Inflammatory [eg gastroesophageal reflux disease (GERD), allergic rhinitis, vasomotor rhinitis, granulomatosis with polyangiitis]
    • Systemic (eg cystic fibrosis, immunodeficiencies, primary ciliary dyskinesia, Kartagener syndrome)
    • Iatrogenic (eg sinus surgery, nasogastric tubes, nasal packing, mechanical ventilation)
    • Other factor (eg exposure to cigarette smoking)

 Recent Antibiotic Use

  • Recent antibiotic use (<90 days) is a major risk factor associated with increased risk of carriage and infection due to resistant pathogens

Other Risk Factors For Resistant Pathogens

  • Age <2 years
  • Attendance in daycare centers
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.